newsfilter
← Latest News
Business Wire·

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

Recognition highlights growing global impact of rare disease diagnosis and the role of genomics in transforming health outcomes GeneDx (NASDAQ:WGS), the leader in rare disease diagnosis and improving health through